lymphatic vessel hyperplasia_Tg(KRT14-FIGF)2Ali/0

http://metadb.riken.jp/0004106IFVBNTgKRT14FIGF2Ali0TgKRT14FIGF2Ali

lymphatic vessel hyperplasia_Tg(KRT14-FIGF)2Ali/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 2, Kari Alitalo
  http://metadb.riken.jp/db/mgi_rdf/MGI:3805116

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(KRT14-FIGF)2Ali/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(KRT14-FIGF)2Ali

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• lymphatic vessel hyperplasia
  http://purl.obolibrary.org/obo/MP_0004106

文献

http://purl.org/net/cito/citesAsAuthority

• T. Veikkola, et.al., Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice., The EMBO journal, 2001, 20
  http://rdf.ncbi.nlm.nih.gov/pubmed/11250889
• Paula. Haiko, et.al., Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos., Molecular and cellular biology, 2008, 28
  http://rdf.ncbi.nlm.nih.gov/pubmed/18519586